Cited by 2,502Cancer, Hypoxia, and MetabolismAngiogenesis and VEGF in CancerErythropoietin and Anemia Treatment

Role of HIF-1α in hypoxia-mediated apoptosis, cell proliferation and tumour angiogenesis

Carmeliet, Peter, Dor, Yuval, Herbert, Jean-Marc, Fukumura, Dai, Brusselmans, Koen, Dewerchin, Mieke, Neeman, Michal, Bono, Françoise +8 more·1998·Nature

Abstract

As a result of deprivation of oxygen (hypoxia) and nutrients, the growth and viability of cells is reduced. Hypoxia-inducible factor (HIF)-1alpha helps to restore oxygen homeostasis by inducing glycolysis, erythropoiesis and angiogenesis. Here we show that hypoxia and hypoglycaemia reduce proliferation and increase apoptosis in wild-type (HIF-1alpha+/+) embryonic stem (ES) cells, but not in ES cells with inactivated HIF-1alpha genes (HIF-1alpha-/-); however, a deficiency of HIF-1alpha does not affect apoptosis induced by cytokines. We find that hypoxia/hypoglycaemia-regulated genes involved in controlling the cell cycle are either HIF-1alpha-dependent (those encoding the proteins p53, p21, Bcl-2) or HIF-1alpha-independent (p27, GADD153), suggesting that there are at least two different adaptive responses to being deprived of oxygen and nutrients. Loss of HIF-1alpha reduces hypoxia-induced expression of vascular endothelial growth factor, prevents formation of large vessels in ES-derived tumours, and impairs vascular function, resulting in hypoxic microenvironments within the tumour mass. However, growth of HIF-1alpha tumours was not retarded but was accelerated, owing to decreased hypoxia-induced apoptosis and increased stress-induced proliferation. As hypoxic stress contributes to many (patho)biological disorders, this new role for HIF-1alpha in hypoxic control of cell growth and death may be of general pathophysiological importance.

Integrity signals

Registry

Crossref · 10.1038/28867

Cites

2 of 2 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • Vascularization is severely impaired in HIF1A-/- and HIF2A-/- mice.

    “Vascularization is severely impaired in HIF1A -/- (Carmeliet et al., 1998;Ryan et al., 1998) and HIF2A -/- (Peng et al., 2000) mice.”

    From Therapeutic targeting of hypoxia and hypoxia-inducible factors in cancer (2016) · cites this paper as Carmeliet et al., 1998

Cites

Flagged first, then by citations

Cited by

Sorted by citations

Authors
Carmeliet, P., Dor, Y., Herbert, J.-M., Fukumura, D., Brusselmans, K., Dewerchin, M., Neeman, M., Bono, F., Abramovitch, R., Maxwell, P., Koch, C. J., Ratcliffe, P., Moons, L., Jain, R. K., Collen, D., & Keshet, E.
Affiliations
  • Vlaams Instituut voor Biotechnologie (BE)
  • Hebrew University of Jerusalem (IL)
  • Sanofi (France) (FR)
  • Harvard University (US)
  • Weizmann Institute of Science (IL)
  • Centre for Human Genetics (GB)
  • University of Pennsylvania (US)
Corresponding author
Carmeliet, Peter
Venue
Nature
Published
1998-07-30
Volume
394
Issue
6692
Pages
485-490
ISSN
  • 0028-0836 (ISSN-L)
  • 1476-4687
OpenAlex
W1578283200
Cited by
2,502
References
2
Citations by year
2026: 37 · 2025: 41 · 2024: 54 · 2023: 59 · 2022: 78 · 2021: 100 · 2020: 67 · 2019: 57 · 2018: 59 · 2017: 78 · 2016: 90 · 2015: 86 · 2014: 105 · 2013: 102 · 2012: 83
FWCI
38.21
Type
journal article
Language
en
Update notices
erratum (1998-10-01)
Open access
closed
Locations
  • Nature (publishedVersion)
  • PubMed (publishedVersion)
  • RePEc: Research Papers in Economics (submittedVersion)
  • Lirias (submittedVersion)
Funders
Wellcome Trust
Topics
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Cancer Research › Cancer, Hypoxia, and Metabolism
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Angiogenesis and VEGF in Cancer
  • Health Sciences › Medicine › Hematology › Erythropoietin and Anemia Treatment
Keywords
HIF-1α, hypoxia, apoptosis, cell proliferation, tumor angiogenesis, hypoglycemia, embryonic stem cells, vascular endothelial growth factor, p53, p21, Bcl-2, p27, GADD153, cell cycle regulation, tumor hypoxia, oxygen homeostasis
MeSH terms
Animals, Cell Division, Cell Line, DNA-Binding Proteins, Glucose, Cricetinae, Lymphokines, Mice, Nude, Neoplasms, Experimental, Neovascularization, Pathologic, Nuclear Proteins, Oxygen, Regional Blood Flow, Stem Cells, Transcription Factors, Cell Hypoxia, Endothelial Growth Factors, CHO Cells, Apoptosis, Gene Targeting, Vascular Endothelial Growth Factors, Vascular Endothelial Growth Factor A, Mice, Hypoxia-Inducible Factor 1, Hypoxia-Inducible Factor 1, alpha Subunit

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review